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Abstract
Background: We investigated to what degree environmental exposure (childhood trauma, urbanicity, cannabis use,
and discrimination) impacts symptom connectivity using both continuous and categorical measures of psychopathology.
Methods: Outcomes were continuous symptom dimensions of self-reported psychopathology using the Self-report
Symptom Checklist-90-R in 3021 participants from The Early Developmental Stages of the Psychopathology (EDSP)
study and binary DSM-III-R categories of mental disorders and a binary measure of psychotic symptoms in 7076
participants from The Netherlands Mental Health Survey and Incidence Study (NEMESIS-1). For each symptom
dimension in the EDSP and mental disorder in the NEMESIS-1 as the dependent variable, regression analyses were
carried out including each of the remaining symptom dimensions/mental disorders and its interaction with cumulative
environmental risk load (the sum score of environmental exposures) as independent variables.
Results: All symptom dimensions in the EDSP and related diagnostic categories in the NEMESIS-1 were strongly
associated with each other, and environmental exposures increased the degree of symptom connectivity in the
networks in both cohorts.
Conclusions: Our findings showing strong connectivity across symptom dimensions and related binary diagnostic
constructs in two independent population cohorts provide further evidence for the conceptualization of psychopathology
as a contextually sensitive network of mutually interacting symptoms.
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Background
Psychopathology traditionally is represented as categor-
ies that implicitly refer to nosological entities (e.g. Major
Depressive Disorder) or trans-diagnostic symptom di-
mensions based on symptom-level clustering (e.g. sever-
ity of depressive symptoms). Vinogradov and colleagues
[1] proposed an associationist model of the symptom di-
mension of paranoia and suggested that the origins of
psychopathology may lie in a network of mental states
giving rise to acute phase transitions that Odgers and
colleagues showed can be modelled as part of a dynamic
system [2]. According to recent elaborations and exten-
sions of this model, psychopathology can be conceptual-
ized as a network of causally linked sets of symptoms,
which reciprocally impact on each other over time to
progress toward a more distinct syndrome forged
through a specific pattern of a dynamic network for each
syndrome [3–6].
The conceptualization of psychopathology as a dy-
namic network of symptoms may provide a particularly
useful tool to understand pathways to mental illness. For
example, transition of a false belief to a crystallized delu-
sion can be modelled as a vicious cycle composed of
interacting steps, in which an initial paranoid state, aris-
ing out of malformed hyperconnectivity among tempor-
ally contiguous perceptions, becomes fixated through
perpetuation of an internally generated maladaptive
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schema to explain odd experiences [1]. Hyperconnectiv-
ity may also expand through the network across symp-
tom domains, triggering a chain reaction, wherein the
primary false belief (e.g. persecutory delusional ideation)
may provoke anxiety under certain circumstances (e.g.
being in public), which in turn leads to a misperception
of external stimuli (illusions and hallucinations) that cre-
ates added confusion and anxiety which further impairs
logical thought process, and solidifies delusionary ex-
planation that finally becomes a fixed delusion.
Recent findings in large general population cohort
studies suggest that exposure to environmental risk
factors (childhood trauma, urbanicity, cannabis use, and
discrimination) reinforces connectivity between symp-
toms of affective dysregulation and psychosis expression
in a dose response fashion, in accordance with the the-
ory of environment-induced disturbances spreading
through the psychopathology network, increasing psych-
osis admixture, and progressively expanding and reinfor-
cing connectivity that ultimately gives rise to transition
to a more severe, distinct clinical syndrome requiring
medical care [7–12].
If the environment impacts on the connection between
psychosis and affective dysregulation, the question rises
to what degree this is specific for these two domains of
psychopathology. An alternative explanation is that the
environment broadly impacts on the connectivity be-
tween domains of psychopathology. The emergence of
psychosis may then be seen as an indicator of general se-
verity of increasingly connected psychopathology, rather
than a specific illness category [9, 13–15]. In the light of
these findings, we hypothesize that the degree of expos-
ure to environmental factors that are known to be asso-
ciated with mental health would increase the extent of
connectivity between symptom dimensions. Therefore,
the aim was to investigate to what degree environmental
exposure impacts on symptom connectivity analysing
measures of psychopathology in two independent, gen-
eral population datasets. In order to examine to what de-
gree the findings would be stable across categorically
and dimensionally defined psychopathology, connectivity
was examined at the level of both continuous dimen-
sions of self-reported psychopathology using the Self-
report Symptom Checklist-90-R (SCL-90-R) and binary
DSM-III-R categories of mental disorders and a binary
measure of psychotic symptoms.
Methods
Samples
The Early Developmental Stages of the Psychopathology
(EDSP) study
The EDSP study collected information on the prevalence,
incidence, risk factors, comorbidity and course of mental
symptoms and syndromes in a random representative
population sample of 3021 adolescents and young adults
living in the Munich area (aged 14–24 years at baseline) at
4 waves: at baseline (T0e), and at 3 follow-ups after on
average 1.6 (T1e), 3.5 (T2e), and 8.4 years (T3e), respect-
ively. Details were provided elsewhere [16–18].
The Netherlands Mental Health Survey and Incidence Study
(NEMESIS-1)
The NEMESIS-1 study collected information on the
prevalence, incidence, and course of mental disorders in
a random representative general population sample of
7076 at 3 waves: at baseline (T0n), at the 12-month
follow-up (T1n), and at the 36-month follow-up (T2n).
Details were provided elsewhere [19].
The EDSP project has been approved by the Ethics
Committee of the Faculty of the Technische Universitat
Dresden (No. EK-13811). The NEMESIS-1 was con-
ducted with the approval of the ethics committee of the
Netherlands Institute of Mental Health and Addiction,
Utrecht, the Netherlands. All respondents provided in-
formed consent.
Instruments
Assessment of psychopathology
EDSP
At each time point, participants completed the SCL-90-
R, a comprehensive self-report symptom inventory,
multidimensional in nature, and oriented to screen for a
broad range of psychological problems and psychopath-
ology in community respondents and respondents with
somatic and mental disorders. The SCL-90-R contains
90 items, scored on a 5-point severity scale, measuring 9
primary symptom dimensions named “somatization,”
“obsessive-compulsive,” (OC) “interpersonal sensitivity,”
“depression,” “anxiety,” “hostility”, “phobic anxiety,”
“paranoid ideation,” and “psychoticism.” Reliability and
validity of the SCL-90-R are quite satisfactory [20]. The
time frame is the past 2 weeks.
Consistent with previous analyses in this sample, the
paranoid ideation and psychoticism dimensions were com-
bined to create a single “psychosis” dimension [9, 21, 22].
NEMESIS-1
The CIDI version 1.1 (computerized version) [23] was
used to diagnose DSM III-R mental disorders. The CIDI
is a structured interview developed by the World Health
Organization and has been found to have high inter-
rater reliability and high test–retest reliability for most
common mental diagnoses [24]. The following diagnoses
were included in the current analysis: manic episode,
major depression, dysthymia and any anxiety disorder
(panic disorder, agoraphobia, simple phobia, social phobia,
generalized anxiety disorder, and obsessive–compulsive
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disorder). Diagnoses represent lifetime presence at base-
line and interval presence at follow-up interviews.
In addition, a binary measure of any clinically relevant
psychotic symptom [25] was used as a measure of psych-
osis [26]. Previous studies using the CIDI showed that
the instrument a reliable and valid assessment of mental
disorders, with the exception of psychotic disorders [27].
The CIDI psychosis section consists of 17 psychosis
items concerning delusions (13 items) and hallucinations
(4 items). Each item is scored on a 1–6 scale: 1,″ no
symptom; 2,″ psychotic symptom present but not
clinically relevant; 3,″ psychotic symptom result of
drug use; 4,″ psychotic symptom result of somatic
disease; 5,″ true psychotic symptom; and 6,″ possible
plausible explanation for what appears to be a psychotic
symptom. Each participant with a score of 2, 5, or 6 was
followed up for validation. Individuals endorsing at least one
lifetime psychotic symptom were interviewed using ques-
tions from the Structured Clinical Interview for Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition
(SCID-I) over the telephone by an experienced clinician [28].
Assessment of Trauma
EDSP
Self-reported lifetime (baseline) and interval (follow-up)
exposure to trauma was assessed using the N-section of
the DIA-X/M-CIDI on trauma and PTSD comprising 9
groups of specific traumatic events (presented by a re-
spondent list) such as “experienced physical threat,” “ex-
perienced serious accident,” or “being sexually abused as
a child.” Visual presentation of the list allowed respon-
dents and interviewers to avoid speaking about some-
times embarrassing and stigmatising trauma by simply
indicating the number of the event. Consistent with earl-
ier analyses [14, 29], positive responses to any of the
events were coded as “self-reported trauma.”
NEMESIS-1
Subjects were asked, using a semi-structured interview,
whether they had experienced any kind of emotional,
physical, psychological or sexual abuse before age 16 years,
providing examples for each type of trauma. Subjects an-
swered ‘yes’ or ‘no’ to each of the questions and were
asked to give an indication about the frequency on a six-
point scale: 1, never; 2, once; 3, sometimes; 4, regular; 5,
often; 6, very often. Consistent with previous work [30], in
the analyses, experience of trauma was a priori dichoto-
mized as follows: ‘no early trauma’ if the score on any item
was ≤3, and ‘early trauma’ if the score on any item was >3.
Assessment of cannabis use
EDSP
Cannabis use was assessed with the L-section of the
DIA-X/M-CIDI using the question “Have you ever used
cannabis five times or more?” to define cannabis expos-
ure. Conforming to previous work [22, 31], the DIA-X/
M-CIDI cut-off of use of five times or more was used to
define the binary variable for cannabis exposure.
NEMESIS-1
Consistent with previous work [32], the L-section of the
CIDI 1.1 was used to define use of cannabis. In keeping
with the previous work, “cannabis use,” was defined as
use of cannabis a least once in the lifetime [32, 33].
Assessment of urbanicity
EDSP
In agreement with earlier work [14, 34], urbanicity was
defined as living, at baseline, in the urban region of the
German city of Munich versus the surrounding areas of
Munich. The urban area, hence defined, had a popula-
tion density of 4061 persons per square mile; for the
rural area, this was 553 persons per square mile.
NEMESIS-1
Guided by previous work [28, 35], the original five-level
classification of the urbanization measure expressed as
density of addresses per km2 was dichotomized as fol-
lows: levels 1 (<500), 2 (500–900) and 3 (1000–1499)
were coded as 0 and levels 4 (1500–2499) and 5 (≥2500)
as 1.
Assessment of discrimination
NEMESIS-1
Perceived discrimination was assessed only in the
NEMESIS-1 and not in EDSP. At baseline, participants
were asked if they had experienced discrimination over
the past year because of their skin colour or ethnicity;
gender; age; appearance; disability; or sexual orientation
[11]. Experienced discrimination was dichotomized as
follows: ‘experienced discrimination’ if the participant
answered one or more of the questions with “Yes”, and
‘no discrimination’ if the participant answered all ques-
tions with “No” [36].
Statistical analysis
All analyses were carried out with Stata 13.1 [37].
EDSP
Given the fact that outcome was measured at each time
point, and in keeping with previous work [14, 38], data
were analysed in the “long format” [each individual con-
tributing 4 observations (T0e, T1e, T2e, and T3e)]. The
analyses, therefore, were cross-sectional. Multilevel regres-
sion models using the XTREG command were applied to
analyse whether the association between symptom dimen-
sions increased as a function of the extent of exposure to
environmental risk factors (continuous variable: from 0 =
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no exposure, to 3 = exposure to all environmental factors),
hereafter referred to as ‘environmental exposure score’.
Therefore, for each symptom dimension as the dependent
variable, analyses were carried out including, in separate
models, each of the 7 other symptom dimensions, and its
interaction with environmental exposure score as inde-
pendent variables. In order to correct for the clustering of
multiple observations within subjects, all analyses were
controlled by adding subject ID to the models as random
intercepts.
NEMESIS-1
Given the fact that outcomes were similarly measured at
each time point, data were analysed in the “long format”
[each individual contributing 3 observations (T0n, T1n,
T2n)]. To calculate the statistical interaction under an
additive model (similar to the EDSP analyses described
above), the BINREG procedure, which fits generalized
linear models for the binomial family estimating risk dif-
ferences, was used to model interactions between envir-
onmental exposure score (the categories of 3 and 4
exposures were merged due to small numbers in the lat-
ter to create a continuous variable: from 0 = no expos-
ure, to 3 = exposure to ≥3 environmental factors) and
diagnostic domains. Therefore, for each of the mental
disorders as the dependent variable, analyses were car-
ried out including each of the other 4 diagnostic do-
mains and its interaction with environmental exposure
score as independent variables. In order to correct for
clustering of multiple observations within subjects, all
analyses were controlled by adding subject ID to the
models as random intercepts.
Results
Characteristics of the study populations at different time
points are shown in Tables 1 and 2.
Symptom connectivity in the EDSP
All symptom dimensions were strongly connected to
each other, and several significant interactions between
symptom dimensions and environmental exposure score
were found (Fig. 1a). With the exception of interpersonal
sensitivity, for which reduced associations were apparent
in the context of greater environmental exposure, con-
nectivity between symptom dimensions increased with
greater level of exposure to environmental risk factors
(Table 3).
Environmental exposure increased associations of
depression with other symptom dimensions except
phobia. Similarly, significant interactions were found
between the environmental exposure score and (i)
interpersonal sensitivity, (ii) OC, and (iii) hostility in
models predicting psychosis; and (i) hostility, and (ii)
interpersonal sensitivity in models predicting OC. Re-
gression analyses predicting anxiety revealed that
associations with other symptom dimensions with the
exception of somatization, increased as a function of
the environmental exposure score.
Table 1 Characteristics of the population at different time points (EDSP)
T0e (n = 3021) T1e (n = 1228)* T2e (n = 2548) T3e (n = 2210)
M (SD) M (SD) M (SD) M (SD)
Sex (male)a 1533 (50.74) 637 (51.87) 1297 (50.90) 1135 (51.36)
Age 18.26 (3.34) 16.72 (1.19) 21.74 (3.39) 26.62 (3.47)
Symptom dimension scoresb
Anxiety 1.33 (0.37) 1.22 (0.32) 1.19 (0.28) 1.17 (0.31)
Depression 1.43 (0.46) 1.31 (0.39) 1.32 (0.39) 1.30 (0.41)
Hostility 1.45 (0.50) 1.34 (0.45) 1.29 (0.40) 1.24 (0.35)
Interpersonal sensitivity 1.48 (0.49) 1.33 (0.43) 1.35 (0.43) 1.28 (0.39)
Obsessive-compulsive 1.47 (0.44) 1.36 (0.40) 1.35 (0.38) 1.32 (0.38)
Phobic anxiety 1.24 (0.30) 1.17 (0.26) 1.17 (0.25) 1.15 (0.26)
Psychosisc 1.31 (0.36) 1.22 (0.32) 1.21 (0.28) 1.17 (0.27)
Somatization 1.35 (0.33) 1.28 (0.29) 1.26 (0.27) 1.26 (0.29)
Environmental loada
Zero 645 (21.35) 286 (23.29) 303 (11.89) 204 (9.23)
One 1711 (56.64) 694 (56.51) 1045 (41.01) 773 (34.98)
Two 556 (18.40) 210 (17.10) 980 (38.46) 958 (43.35)
Three 109 (3.61) 38 (3.09) 220 (8.63) 275 (12.44)
*The sample at T1 only included the younger members of the cohort; assessments at T0, T2 and T3 were based on the full sample. an (%); bSelf-report Symptom
Checklist-90-R (SCL-90-R) symptom dimensions scores; cparanoid ideation and psychoticism dimensions were combined to create a single “psychosis” dimension
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Significant interactions were found between the environ-
mental exposure score and (i) OC, and (ii) interpersonal
sensitivity in models of somatization; and (i) OC, and (ii)
interpersonal sensitivity in models of hostility. Regression
analyses predicting phobia showed significant interactions
between the environmental exposure score and each of the
symptom dimensions. Regression analyses predicting sen-
sitivity showed that associations between sensitivity and (i)
anxiety, (ii) psychosis, and (iii) depression decreased as a
function of the environmental exposure score.
Symptom connectivity in the NEMESIS-1
All diagnostic domains were strongly connected with each
other, and significant interactions between domains and
the environmental exposure score were found (Fig. 1b).
Regression analyses predicting major depression showed
that only the strength of the association between major de-
pression and anxiety disorders increased as a function of
environmental exposure, whereas environmental exposure
increased the strength of associations between psychotic
symptoms and each of the diagnostic domains (Table 4).
Regression analyses predicting anxiety disorders showed
only the association between anxiety disorders and psych-
otic symptoms increased as a function of environmental
exposure. Significant interactions were found between the
environmental exposure score and (i) major depression,
(ii) psychotic symptoms, and (iii) anxiety disorders in
models predicting mania; as well as (i) major depression
and (ii) anxiety disorders in models of dysthymia (Table 3).
Discussion
This study investigated to what degree connectivity be-
tween symptom dimensions and diagnostic categories is
conditional on environmental exposures known to be as-
sociated with mental ill health, particularly psychosis.
The principal findings were: (i) symptom dimensions
and related diagnostic categories were strongly associ-
ated with each other; (ii) environmental exposures in-
creased the level of connectivity.
Psychopathology as a network of symptoms
Our findings showing strong connectivity across symp-
tom dimensions and related binary diagnostic constructs
in two independent population cohorts confirm previous
results [9], and provide additional evidence for the
conceptualization of psychopathology as a network of
mutually interacting symptoms [3–6]. Several studies in
general population cohorts have shown that symptom
domains do not vary in isolation but are intercon-
nected, even before the emergence of a distinct clinical
state, and that interactions between symptoms, includ-
ing transdiagnostic ‘contiguous symptoms’ (e.g. halluci-
nations x delusions) and ‘disjointed symptoms’ (e.g.
affective dysregulation x paranoia) predict transition to
a more severe mental state [39–41]. Micro-level re-
search of psychopathology at the level of momentary
experiences in the flow of daily life using the Experi-
ence Sampling Method (ESM) has demonstrated that
there is a continuous dynamic interplay between moment-
ary mental states, with increasing connectivity between
momentary states (paranoia, positive, and negative affect)
predicting increased severity [42] and onset of need for
care [43]. Similarly, an investigation of the underlying dy-
namic network structure of psychopathology revealed that
mental states of individuals with psychosis or depression
were more connected than those of healthy controls, with
Table 2 Characteristics of the population at different time points (NEMESIS-1)
T0n (n = 7076) T1n (n = 5618) T2n (n = 4848)
n (%) n (%) n (%)
Sex (male) 3299 (46.63) 2611 (46.48) 2255 (46.51)
Agea 41.16 (12.19) 42.09 (11.94) 44.19 (11.90)
Diagnostic categoriesb
Anxiety disordersc 1423 (20.11) 430 (7.65) 332 (6.85)
Dysthymia 498 (7.04) 110 (1.96) 71 (1.46)
Major depression 1164 (16.45) 314 (5.59) 306 (6.31)
Manic episode 293 (4.14) 84 (1.50) 48 (0.99)
Psychosisd 295 (4.17) 72 (1.28) 45 (0.93)
Environmental load
Zero 3171 (44.82) 2623 (46.69) 2285 (47.13)
One 2640 (37.31) 2173 (38.68) 1886 (38.90)
Two 961 (13.58) 670 (11.93) 553 (11.41)
Three or more 303 (4.28) 152 (2.71) 124 (2.56)
aMean (standard deviation); bbinary lifetime diagnostic constructs according to the CIDI version 1.1 structured interview; cincludes panic disorder, agoraphobia,
simple phobia, social phobia, generalized anxiety disorder, and obsessive–compulsive disorder; dbinary measure of any clinically relevant psychotic symptom
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more feedback loops across negative momentary mental
states (e.g. “insecure”, “suspicious”) [44]. There is some
evidence that an alteration in the pattern of mood dynam-
ics, marked by increased connectivity across the network,
may give rise to an unstable condition, or tipping point,
where even a subthreshold stimulus may provoke an
abrupt transition to clinical depression [45].
The impact of environmental exposures on the
psychopathology network
The findings indicating increased symptom connectivity
as a function of the level of environmental exposure score
lend further support to previous findings showing that ex-
posure to environmental risk factors (trauma, urbanicity,
cannabis) additively increase psychosis expression in
affective spectrum disorder in a dose–response fashion
[9]. Smeets and colleagues demonstrated, both in general
population samples [46] and in those at high genetic risk
(siblings and parents of patients) [8] that rates of co-
occurrence of hallucinations and delusions are moderated
by environmental exposure (cannabis use and childhood
trauma). Another recent study in the general population
showed that when symptoms were grouped together to
form a connected symptom domain, association with
childhood trauma became significantly stronger than
when symptoms were analysed in isolation [7]. Simi-
larly, an ESM study showed that childhood adversity
moderated the impact of negative affect on paranoia
levels [47]. Furthermore, meta-analytic work has shown
that environmental exposures increase the way psychotic
symptoms impact on to themselves over time – i.e. the
rate of persistence or the rate of transfer over time. Thus‚
greater level of exposure to childhood trauma predicts in-
creased persistence of psychotic experiences [48].
Strengths and limitations
The major strength of this study is the analysis of hy-
pothesized psychopathology networks at levels of both
continuous symptom dimensions and related binary
diagnostic constructs in two independent large, repre-
sentative population cohorts assessed with standardized
clinical instruments administered by trained inter-
viewers, thus increasing the generalizability of our find-
ings. However, there are several limitations that should
be taken into consideration. First, observations from all
time points were combined in the ‘long format’–cross-
sectional in nature. This is a practical solution at the
current stage, given the lack of a sufficiently large data-
set with intensive repeated assessments over an extended
time frame, allowing for sequential analysis of the associ-
ation between environmental exposures and symptom
connections. While cross-sectional analysis increases re-
liability, it may not be the optimal approach to elucidate
causal associations between environmental exposures
and symptom connectivity over time. Future studies
should therefore aim to investigate large cohorts with
more frequent and fine-grained follow-ups in order to
gain more insight into the dynamic formation of psycho-
pathology networks under the influence of environmen-
tal exposures. Second, based on previous evidence
indicating that environmental factors additively reinforce
each other, possibly impacting on the same underlying
mechanism, environmental risk factors were combined
to construct a cumulative environmental risk load. The
use of a score reflecting combined environmental impact
increased statistical power and reduced type I error. On
the other hand, while environmental factors may not all
contribute equally to the cumulative environmental im-
pact, similar weights were assigned to each environmental
a
b
Fig. 1 The impact of environmental exposure on connectivity across
the symptom network. Fig. 1 (a) represents the EDSP sample. Fig. 1
(b) represents the NEMESIS-I sample. Arrows point out the direction
of the association (from independent variable to dependent variable).
Solid line indicates an increased association between symptom
dimensions as a function of the degree of the environmental exposure.
Dashed line indicates a reduced association between symptom
dimensions as a function of the degree of the environmental
exposure. Anx, Anxiety; Dep, Depression; Dys, Dysthmia; Hos, Hostility;
IPS, Interpersonal Sensitivity; Man, Mania; OC, Obsessive-Compulsive;
Pho, Phobic anxiety; Psy, Psychosis; Som, Somatization
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Table 3 The association between symptom dimensions as a function of exposure to environmental risk factors in the EDSP sample
Dependent Independent B (dimension) B (environment) B (interaction)
Depression Anxiety 0.79*** NS 0.03**
Psychosis 0.94*** NS 0.03**
OCD 0.7*** −0.05*** 0.05***
Somatization 0.62*** NS 0.03*
Phobia 0.93*** NS NS
Hostility 0.55*** NS 0.03***
Sensitivity 0.63*** −0.05*** 0.05***
Psychosis Anxiety 0.62*** NS NS
Depression 0.58*** NS NS
OCD 0.52*** NS 0.01*
Somatization 0.47*** NS NS
Phobia 0.71*** NS NS
Hostility 0.43*** −0.02* 0.02**
Sensitivity 0.52*** −0.03*** 0.03***
Anxiety Depression 0.51*** −0.04*** 0.02**
Psychosis 0.67*** −0.03** 0.02*
OCD 0.49*** −0.05*** 0.03***
Somatization 0.59*** NS NS
Phobia 0.73*** −0.06*** 0.04***
Hostility 0.39*** −0.04*** 0.03***
Sensitivity 0.41*** −0.04*** 0.03***
OCD Anxiety 0.78*** NS NS
Psychosis 0.88*** NS NS
Depression 0.73*** NS NS
Somatization 0.57*** NS NS
Phobia 0.94*** NS NS
Hostility 0.49*** NS 0.02*
Sensitivity 0.54*** −0.04*** 0.04***
Somatization Anxiety 0.51*** NS NS
Psychosis 0.44*** NS NS
OCD 0.32*** −0.04** 0.03**
Depression 0.35*** NS NS
Phobia 0.47*** NS NS
Hostility 0.28*** NS NS
Sensitivity 0.26*** NS 0.02*
Phobia Anxiety 0.48*** −0.04*** 0.04**
Psychosis 0.51*** NS 0.02*
OCD 0.40*** −0.05*** 0.04***
Somatization 0.35*** −0.04** 0.03***
Depression 0.41*** −0.02** 0.02**
Hostility 0.29*** NS 0.02**
Sensitivity 0.32*** −0.04*** 0.04***
Hostility Anxiety 0.74*** NS NS
Psychosis 0.89*** NS NS
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Table 3 The association between symptom dimensions as a function of exposure to environmental risk factors in the EDSP sample
(Continued)
OCD 0.59*** −0.04* 0.02*
Somatization 0.61*** NS NS
Phobia 0.81*** NS NS
Depression 0.69*** NS NS
Sensitivity 0.58*** −0.03* 0.02*
Sensitivity Anxiety 0.86*** 0.05** −0.04***
Psychosis 1.19*** 0.05*** −0.05***
OCD 0.73*** NS NS
Somatization 0.62*** NS NS
Phobia 0.99*** NS NS
Hostility 0.64*** NS NS
Depression 0.88*** 0.04*** −0.05***
Dependent variables for each analysis were reported on the far left column, and next to those were independent variables. For each analysis examining
connectivity between symptom dimensions as a function of exposure to environmental risk factors, unstandardized regression coefficients (B) for symptom
dimension, environmental exposure, and interaction between environmental exposure and symptom dimension were provided, respectively. For example, the first
row shows coefficients from the analysis investigating to what degree the exposure to environment moderated the impact of anxiety predicting depression
NS : non-significant, ***p < 0.001, **p < 0.01, *p < 0.05
Table 4 The association between symptom dimensions as a function of exposure to environmental risk factors in the NEMESIS-1
sample
Dependent Independent RD (dimension) RD (environment) RD (interaction)
Psychosis Depression 0.04*** 0.01*** 0.04***
Anxiety 0.03*** 0.01*** 0.05***
Mania 0.12*** 0.01*** 0.07**
Dysthymia 0.05** 0.02*** 0.04**
Depression Psychosis 0.23*** 0.05*** NS
Anxiety 0.21*** 0.04*** 0.05***
Mania 0.35*** 0.05*** NS
Dysthymia 0.55*** 0.05*** NS
Anxiety Psychosis 0.29*** 0.05*** 0.05*
Depression 0.29*** 0.04*** NS
Mania 0.41*** 0.05*** NS
Dysthymia 0.37*** 0.05*** NS
Mania Psychosis 0.12*** 0.02*** 0.08***
Anxiety 0.04*** 0.01*** 0.06***
Depression 0.05*** 0.01*** 0.03***
Dysthymia 0.06*** 0.02*** NS
Dysthymia Psychosis 0.10*** 0.02*** NS
Anxiety 0.10*** 0.01*** 0.03***
Mania 0.15*** 0.02*** NS
Depression 0.20*** 0.01*** 0.02*
Dependent variables for each analysis were reported on the far left column, and next to those were independent variables. For each analysis examining
connectivity between symptom dimensions as a function of exposure to environmental risk factors, risk differences (RD) for symptom dimension, environmental
exposure, and interaction between environmental exposure and symptom dimension were provided, respectively. For example, the first row shows risk differences from
the analysis investigating to what degree the exposure to environment moderated the impact of depression predicting psychosis
NS: non-significant, ***p < 0.001, **p < 0.01, *p < 0.05
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factor, which may have produced a degree of imprecision
to the results.
Conclusions
Evidence indicates that environmental risk factors im-
pact on connections between symptoms in a causal net-
work, increasing connectivity, thus adding to tipping the
balance towards transition from the initial set of sub-
threshold symptoms to a more severe mental state and a
more distinct clinical syndrome requiring treatment.
Under the framework of connected symptoms in a
network, future research may focus on the divergent and
interactive impacts of vulnerability factors (environmen-
tal and genetic) on pattern formation across symptoms
and mental states, and investigate whether there are spe-
cific patterns in the network that may be useful to differ-
entiate and predict psychopathology at disorder and
symptom levels. Despite high cost, the optimal research
design would require a large enough cohort with a longi-
tudinal design to assess psychopathology (both at micro
and macro levels) and environmental exposures over a
longer period of time, spanning the period of transition
from a normal to a clinical state e.g. in late adolescence
and early adulthood. A more practical approach to
understanding changes of network patterns leading to
progression to a clinical syndrome may be to use a
sibling-case–control design providing the opportunity to
investigate the symptom network at different levels of
genetic and non-genetic susceptibility [49].
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